KR100360568B1 - 16-membered ring macrolide derivative and method for manufacturing the same - Google Patents
16-membered ring macrolide derivative and method for manufacturing the same Download PDFInfo
- Publication number
- KR100360568B1 KR100360568B1 KR1019940016581A KR19940016581A KR100360568B1 KR 100360568 B1 KR100360568 B1 KR 100360568B1 KR 1019940016581 A KR1019940016581 A KR 1019940016581A KR 19940016581 A KR19940016581 A KR 19940016581A KR 100360568 B1 KR100360568 B1 KR 100360568B1
- Authority
- KR
- South Korea
- Prior art keywords
- membered ring
- manufacturing
- same
- macrolide derivative
- ring macrolide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP16941893A JP3023041B2 (ja) | 1993-07-08 | 1993-07-08 | 新規16員環マクロリド誘導体 |
JP5300686A JPH07149788A (ja) | 1993-11-30 | 1993-11-30 | 新規16員環マクロリド誘導体及びそれらの効率的製造法 |
JP6105096A JPH07309889A (ja) | 1994-05-19 | 1994-05-19 | 新規16員環マクロリド誘導体及びそれらの新規製造法 |
JP6126654A JPH07330791A (ja) | 1994-06-08 | 1994-06-08 | 新規16員環マクロリド誘導体及びそれらの新規包括的製造法 |
JP6145125A JPH0812696A (ja) | 1994-06-27 | 1994-06-27 | 新規16員環マクロリド誘導体及びそれらの効率的製造法 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR100360568B1 true KR100360568B1 (en) | 2003-03-12 |
Family
ID=27526205
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019940016581A KR100360568B1 (en) | 1993-07-08 | 1994-07-08 | 16-membered ring macrolide derivative and method for manufacturing the same |
Country Status (8)
Country | Link |
---|---|
US (1) | US5602106A (ko) |
EP (1) | EP0633266B1 (ko) |
KR (1) | KR100360568B1 (ko) |
CN (2) | CN1046534C (ko) |
AT (1) | ATE165604T1 (ko) |
CA (1) | CA2127578A1 (ko) |
DE (1) | DE69409874T2 (ko) |
ES (1) | ES2115816T3 (ko) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1191031A4 (en) * | 1999-06-01 | 2002-09-18 | Meiji Seika Kaisha | LEUCOMYCIN DERIVATIVES MODIFIED IN POSITION 3 |
EP2029147B1 (en) | 2006-06-12 | 2010-05-19 | Ramot at Tel-Aviv University Ltd. | Methods for treating cancer |
CN102344946B (zh) * | 2010-08-02 | 2014-06-25 | 中牧实业股份有限公司 | 一种生物转化合成普拉特霉素a1的方法 |
EP2671887A4 (en) * | 2011-01-31 | 2014-06-25 | Meiji Seika Pharma Co Ltd | NEW MACROLIDE DERIVATIVE |
KR20150098675A (ko) | 2012-12-24 | 2015-08-28 | 라모트 앳 텔-아비브 유니버시티 리미티드 | 넌센스 돌연변이로부터 생긴 유전적 질환을 치료하기 위한 물질 및 이를 확인하는 방법 |
AU2018247555B2 (en) * | 2017-04-06 | 2024-04-18 | Shenyang Fuyang Pharmaceutical Technology Co., Ltd. | Use of carrimycin and pharmaceutically acceptable salt thereof for manufacture of medicament for treatment and/or prevention of tumors |
ES2912734T3 (es) * | 2017-07-04 | 2022-05-27 | Shenyang Fuyang Pharmaceutical Tech Co Ltd | Uso de isovaleril espiramicina I o III en la preparación de fármaco para tratar y/o prevenir el tumor y fármaco |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2638458A1 (fr) * | 1988-10-27 | 1990-05-04 | Adir | Nouveaux derives de la tylosine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
JP3063943B2 (ja) * | 1992-02-26 | 2000-07-12 | 明治製菓株式会社 | 血漿中において抗菌活性の持続する新規16員環マクロリド誘導体及びその合成中間体とそれらの製造法 |
DE69324434T2 (de) * | 1992-10-29 | 1999-12-23 | Meiji Seika Kaisha Ltd., Tokio/Tokyo | 16-Gliederige Makrolid-Derivate und Verfahren zu deren Herstellung |
-
1994
- 1994-07-07 CA CA002127578A patent/CA2127578A1/en not_active Abandoned
- 1994-07-08 US US08/271,996 patent/US5602106A/en not_active Expired - Fee Related
- 1994-07-08 AT AT94110679T patent/ATE165604T1/de not_active IP Right Cessation
- 1994-07-08 KR KR1019940016581A patent/KR100360568B1/ko not_active IP Right Cessation
- 1994-07-08 EP EP94110679A patent/EP0633266B1/en not_active Expired - Lifetime
- 1994-07-08 CN CN94115983A patent/CN1046534C/zh not_active Expired - Fee Related
- 1994-07-08 DE DE69409874T patent/DE69409874T2/de not_active Expired - Fee Related
- 1994-07-08 ES ES94110679T patent/ES2115816T3/es not_active Expired - Lifetime
-
1998
- 1998-07-23 CN CN98116380A patent/CN1093134C/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP0633266B1 (en) | 1998-04-29 |
CN1046534C (zh) | 1999-11-17 |
CN1219539A (zh) | 1999-06-16 |
US5602106A (en) | 1997-02-11 |
DE69409874D1 (de) | 1998-06-04 |
DE69409874T2 (de) | 1999-01-21 |
EP0633266A1 (en) | 1995-01-11 |
CN1093134C (zh) | 2002-10-23 |
CA2127578A1 (en) | 1995-01-09 |
CN1106818A (zh) | 1995-08-16 |
ES2115816T3 (es) | 1998-07-01 |
ATE165604T1 (de) | 1998-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69127457D1 (en) | 6-0-methylerythromycin a-derivat | |
AU4022393A (en) | 5-O-desosaminylerythronolide a derivative | |
CA2009741A1 (en) | Selective antibacterial agent | |
BG103673A (en) | 3'-n-oxide, 3'-n-dimethylamine, 9-oxime derivatives of erythromycin a | |
ES8704943A1 (es) | Un procedimiento para la fabricacion de derivados de cefalosporina. | |
IL123551A0 (en) | Tricyclic erythromycin derivatives | |
AU4761693A (en) | Benzopyran and benzoxazine derivatives | |
KR100360568B1 (en) | 16-membered ring macrolide derivative and method for manufacturing the same | |
MD1788F2 (en) | Erythromycin A 9-O-oximes derivatives, pharmaceutical composition on base thereof and method of treatment of infectious diseases | |
AU6475600A (en) | Antibiotic caprazamycins and process for producing the same | |
HRP940251B1 (en) | Process for the preparation of azithromycin dihydrochloride | |
EP0670317A4 (ko) | ||
CA2146322A1 (en) | Oleaginous compositions | |
AU548292B2 (en) | 3-3-demethyl derivatives of istamycin b series compounds | |
ZA91570B (en) | A novel antibiotic,deoxymulundocandin,a process for its production and its use as medicament | |
HU9503388D0 (en) | Anxiolytic agent | |
ZA943426B (en) | Synthetic aglucodalbaheptide antibiotics | |
CS106784A2 (en) | Zpusob vyroby 19 epi dianemycinu | |
EP0657412A4 (ko) | ||
MX9605773A (es) | Compuestos de cefalosporina y procesos para la preparacion de los mismos. | |
CA2122705A1 (en) | Optically Active 1-Phenylpyrrolidone Derivative, Intermediate for Producing the Same, and Process for Producing Both | |
MX9701853A (es) | Antibiotico especifico de legionella, micro-organismo que produce el antibiotico y proceso para producir el mismo. | |
NO951309L (no) | Forbindelser for bruk som additiver i oljeholdige sammensetninger |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
LAPS | Lapse due to unpaid annual fee |